COMPANY

Lamassu Biotech

Lamassu Biotech is advancing multiple drugs through clinical trials, including its cancer treatment targeting p53 wild-type tumors and therapy to treat acute pancreatitis. From company website Source · Oct 12, 2026

Keywords: clinical trials cancer

Profile checked Oct 10, 2026

Timeline

Jun 3, 2025 Grant Government grant announced Jun 3, 2025. Source: company's own press page. source ↗
May 16, 2025 Partnership Partnership / licensing announced May 16, 2025. Source: company's own press page. source ↗

Funding

Last 2 years.

May 16, 2025 Partnership / licensing announced May 16, 2025. Source: company's own press page. source ↗
Jun 3, 2025 Government grant announced Jun 3, 2025. Source: company's own press page. source ↗